Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of rosiglitazone on bone metabolism and
to assess the association between the changes in bone turnover parameters and plasma cytokine
levels in postmenopausal diabetic women